Percutaneous nephrolithotomy (PCN) has become the technique of choice for the treatment of large stones larger than 2 cm or after failure of other techniques. Thus, its unilateral performance has become a routine technique, but bilateral percutaneous nephrolithotomy in one stage is not common practice. This therapeutic option appears attractive in patients at high risk of recurrence and unable to tolerate a two-stage PCN, however it must be performed in expert reference centers. The objective of our study is to retrospectively evaluate the efficacy and morbidity of concomitant bilateral percutaneous nephrolithotomy and to compare the results of our series with those of an extensive and recent review of the literature. This is a retrospective study including 20 cases of concomitant bilateral percutaneous nephrolithotomy performed between January 2011 and January 2023. The mean age was 47.4 years. These were 14 men and 6 women, all had bilateral kidney stones. The mean stone size was 28.8 cm, of which 11 were coralliform. We obtained a good result (Stone-free) in 17 patients with an average duration of 130 min, the residual stones required additional treatment in 3 cases by extracorporeal lithotripsy (ECL).the main complications encountered were hemorrhagic (1 case) and infectious (2 cases), the renal function is unchanged in the end. The results of our series are consistent with those of the literature with a success rate of 85% without residual fragments greater than 4 mm.
Myoid tumor of the testis is a rare neoplasm that originates from the smooth muscle cells of the tunica albuginea. It is usually benign and presents as a painless testicular mass. The diagnosis is confirmed by histopathological examination. The treatment of choice is radical orchiectomy. Recurrence is uncommon, and long-term follow-up is recommended. In this abstract, we review the clinical presentation, diagnosis, treatment, and prognosis of myoid tumor of the testis based on current literature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.